ml 23 has been researched along with Atrophy in 1 studies
*Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chantegrel, J; Claustrat, B; Luu-Duc, C; Marsura, A; Masson-Pévet, M; Pévet, P | 1 |
1 other study(ies) available for ml 23 and Atrophy
| Article | Year |
|---|---|
Failure of N-(2,4-dinitrophenyl)-5-methoxytryptamine (a putative melatonin antagonist) and of N-(3,5-dinitrophenyl)-5-methoxytryptamine to prevent the effects of injections of melatonin in the late afternoon on testicular activity of the golden hamster.
Topics: 5-Methoxytryptamine; Animals; Atrophy; Cold Temperature; Cricetinae; Light; Male; Melatonin; Mesocricetus; Serotonin; Testis | 1989 |